Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Usage Information

Troponin-tropomyosin abnormalities in hamster cardiomyopathy.
A Malhotra, J Scheuer
A Malhotra, J Scheuer
View: Text | PDF
Research Article

Troponin-tropomyosin abnormalities in hamster cardiomyopathy.

  • Text
  • PDF
Abstract

Cardiac myofibrils from cardiomyopathic hamsters exhibit elevated Mg2+ ATPase activity and a parallel upward shift of the calcium ATPase dose response curve. To explore the mechanism, myofibrils from control and cardiomyopathic hamster hearts were incubated with isolated troponin-tropomyosin complex (Tn.Tm) from cardiomyopathic and control hamster or from dog hearts. Tn.Tm from control hamster or dog hearts restored normal Mg2+ ATPase activities to myofibrils from myopathic hearts. However, the maximum ATPase response to calcium stimulation was less in cardiomyopathic myofibrils compared to controls, even when control Tn.Tm was included. Electrophoretic patterns of Tn.Tm from myopathic and control hearts were similar. Electrophoresis of the hamster myofibrils mixed with dog cardiac Tn.Tm and then washed demonstrated binding of this complex to myopathic myofibrils. To further confirm that the incubation experiments resulted in binding, 125I troponin-tropomyosin was cross-hybridized with myofibrils, extensively washed, and then analyzed enzymatically and autoradiographically. Autoradiograms demonstrated similar percent binding of 125I Tn.Tm to all myofibrillar preparations and enzymatic effects like those found using cold Tn.Tm. These studies suggest that Tn.Tm from cardiomyopathic hearts inhibits Mg2+ myofibrillar ATPase activity to a lesser degree than Tn.Tm from control hearts. Decreased stimulation by calcium in myopathic preparations may be due to abnormalities in troponin-tropomyosin and/or to the decreased myosin ATPase activity observed previously.

Authors

A Malhotra, J Scheuer

×

Usage data is cumulative from November 2025 through November 2026.

Usage JCI PMC
Text version 300 3
PDF 190 7
Figure 0 2
Scanned page 599 0
Citation downloads 215 0
Totals 1,304 12
Total Views 1,316
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts